Navigation Links
Irvine Scientific Launches IS CHO-CD XP(TM)
Date:3/6/2009

SANTA ANA, Calif., March 6 /PRNewswire/ -- Irvine Scientific, a leading medical device/biopharmaceutical company located in Santa Ana, California, is proud to announce the addition of IS CHO-CD XP(TM) Culture System to their cell culture product line. IS CHO-CD XP(TM) Culture System is a set of chemically-defined*, serum-free, and animal component free media designed using metabolic-balancing technology to deliver robust cell growth and production for recombinant CHO cell lines. It supports batch, fed-batch, and perfusion culture processes.

The IS CHO-CD XP(TM) Culture System is made up of IS CHO-CD XP(TM) growth medium, IS CHO Feed-CD XP medium, and IS Hydrolysate Blend XP(TM) supplement. All components are fully compatible with other IS CHO products and are available in liquid or powder formats.

With over three decades of life-science innovation Irvine Scientific has expertise in developing world-class cell culture media for the biopharmaceutical industry. They are industrial-scale media manufacturers with a capacity of 800,000 kg/yr (~40 million liters) and continue to be leaders in rapid turnaround time worldwide. Irvine Scientific's ongoing personal service, technical support, and accessibility to key team members ensure that your questions and concerns are addressed every step of the way. Their cGMP facility was the first media manufacturing facility to receive ISO 13485:2003 certification. At Irvine Scientific their staff is virtually an extension of yours.

For more information on Irvine Scientific, visit our website at www.irvinesci.com/xp or contact: Nancy Huezo at nhuezo@irvinesci.com. Phone (800) 437-5706 or (949) 261-7800 ext 238.

*Chemically-defined when used without
'/>"/>

SOURCE Irvine Scientific
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
2. BioMed Realty Trust Appoints Executive Officer of the Irvine Company to Its Board
3. Families of Spinal Muscular Atrophy; University of California, Irvine Stem Cell Scientist; and California Stem Cell Announce Collaboration for Safety Studies for Stem Cell Therapy in Spinal Muscular Atrophy
4. Irvine Dermatologist Begins In-office Clinical Studies -- Nissan Pilest, MD Combines Multi-Use Botox in Laser Resurfacing Clinical Studies
5. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
6. Thermo Fisher Scientific Executive Officers Adopting SEC Rule 10b5-1 Trading Programs
7. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
8. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
9. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
10. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
11. Thermo Fisher Scientific to Present at Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Therapeutics, Inc. today announced that data from pre-clinical studies of ... in vitro and animal models of human chronic myeloid ... upcoming 51st Annual Meeting of the American Society of Hematology ... 2009. The poster will be presented by Stemline,s collaborators at ...
(Date:12/3/2009)... INC. (OTC Bulletin Board: ACCP), ... of MuGard, an FDA approved treatment for oral mucositis, ... MuGard is commercially launched by Access, partner, SpePharm, in ... Greece and Sweden. Access is conducting pre-marketing activities, including ...
(Date:12/3/2009)... Inverness Medical Innovations, Inc. (NYSE: IMA ), a ... health at home through the merger of rapid diagnostics and ... on its Series B Convertible Perpetual Preferred Stock ( IMA-PB). ... stock in an amount per share equal to the quotient ...
(Date:12/2/2009)... Blue Steel is emerging as one of the fastest growing ... True Green Energy Group and True Green Planet,s President and ... business for over 25 years, stated that Spectrum Blue Steel ... stage for spectacular earnings because of the bi products recovered ...
Breaking Biology Technology:Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3
... Program for KOS-1584, HAYWARD, Calif., Oct. ... ) today announced that Roche and Kosan ... collaborative research, development and,commercialization agreement entered into ... period, following which Kosan will reacquire worldwide,rights ...
... Sigma-Aldrich(TM) (Nasdaq:,SIAL), a life science company dedicated ... world,s researchers, and Oxford,BioMedica (LSE: OXB), a leading ... key order confirming the strength and validity of,intellectual ... in,the research field to Sigma-Aldrich. The ruling was ...
... In Vitro Data presented at AACR-NCI-EORTC International ... Molecular Targets and Cancer Therapeutics in ... /PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(TSX: AEZ; Nasdaq: ... therapy and oncology, today presented an abstract ...
Other Biology Technology:Kosan to Reacquire Epothilone Program From Roche 2Kosan to Reacquire Epothilone Program From Roche 3Kosan to Reacquire Epothilone Program From Roche 4Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute 2Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute 3AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment 2AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment 3AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment 4
(Date:12/3/2009)... solar panels that repels grime and dirt? Expanded battery ... Aviv University research, just published in Nature Nanotechnology ... nano-scale level that could make these futuristic visions come ... the range of 100 nanometers (roughly one-billionth of a ...
(Date:12/3/2009)... can undergo a personality change in warmer water, according to ... some species more aggressive. , Experiments with two species of ... the first time that some reef fish are either consistently ... even more marked as water temperatures rise. , A slight ...
(Date:12/3/2009)... UPTON, NY A team of scientists from the ... University, and the Indian Institute of Science has made ... genetic information in DNA that is necessary to carry ... December 1, 2009 edition of Nature Structural & ...
Breaking Biology News(10 mins):A window that washes itself? 2Fish with attitude: Some like it hot 2Grooving down the helix 2Grooving down the helix 3Laboratory Test May Predict Effectiveness of ERBITUX 28R 29 for Individual Colorectal Cancer Patients 12384 1Laboratory Test May Predict Effectiveness of ERBITUX 28R 29 for Individual Colorectal Cancer Patients 12384 2Laboratory Test May Predict Effectiveness of ERBITUX 28R 29 for Individual Colorectal Cancer Patients 12384 3Cimzia 28R 29 28certolizumab pegol 29 Provides Long Term Remission and Response Rates in Infliximab Refractory Crohns Patients 12382 1Cimzia 28R 29 28certolizumab pegol 29 Provides Long Term Remission and Response Rates in Infliximab Refractory Crohns Patients 12382 2Cimzia 28R 29 28certolizumab pegol 29 Provides Long Term Remission and Response Rates in Infliximab Refractory Crohns Patients 12382 3Cimzia 28R 29 28certolizumab pegol 29 Provides Long Term Remission and Response Rates in Infliximab Refractory Crohns Patients 12382 4Cimzia 28R 29 28certolizumab pegol 29 Provides Long Term Remission and Response Rates in Infliximab Refractory Crohns Patients 12382 5Cimzia 28R 29 28certolizumab pegol 29 Provides Long Term Remission and Response Rates in Infliximab Refractory Crohns Patients 12382 6Cimzia 28R 29 28certolizumab pegol 29 Provides Long Term Remission and Response Rates in Infliximab Refractory Crohns Patients 12382 7Cimzia 28R 29 28certolizumab pegol 29 Provides Long Term Remission and Response Rates in Infliximab Refractory Crohns Patients 12382 8Cimzia 28R 29 28certolizumab pegol 29 Provides Long Term Remission and Response Rates in Infliximab Refractory Crohns Patients 12382 9Cimzia 28R 29 28certolizumab pegol 29 Provides Long Term Remission and Response Rates in Infliximab Refractory Crohns Patients 12382 10Shire Presented Results of a New Database Analysis on Lialda 28R 29 28Mesalamine 29 and Other 5 ASAs for Ulcerative Colitis at Digestive Disease Week 4503 1Shire Presented Results of a New Database Analysis on Lialda 28R 29 28Mesalamine 29 and Other 5 ASAs for Ulcerative Colitis at Digestive Disease Week 4503 2Shire Presented Results of a New Database Analysis on Lialda 28R 29 28Mesalamine 29 and Other 5 ASAs for Ulcerative Colitis at Digestive Disease Week 4503 3Shire Presented Results of a New Database Analysis on Lialda 28R 29 28Mesalamine 29 and Other 5 ASAs for Ulcerative Colitis at Digestive Disease Week 4503 4Shire Presented Results of a New Database Analysis on Lialda 28R 29 28Mesalamine 29 and Other 5 ASAs for Ulcerative Colitis at Digestive Disease Week 4503 5
... of societys most pressing environmental problems, from climate change ... natural chemical cycles. Moving toward a sustainable future will ... a huge impact on the Earths chemistry. , ... Studies, Dr. William H. Schlesinger, who has been investigating ...
... treating post trauma, the U.S. armed forces face challenges on ... Department of Defense (DoD) research conference to address such issues ... Conference Center. , The purpose of the conference ... services and representatives, as well as showcase UH research expertise ...
... at New Mexico State University recently discovered the worlds ... pepper originating in Assam, India, has earned Guiness World ... blasting past the previous champion Red Savina. In replicated ... one million SHUs, almost double the SHUs of Red ...
Other Biology News:Biogeochemistry -- A window into the Earth's ecological health 2US Army, US Navy, US Air Force, US Marines, US Department of Defense conference held at UH 2US Army, US Navy, US Air Force, US Marines, US Department of Defense conference held at UH 3
Human Serpin A8/AGT Affinity Purified Polyclonal Ab Keywords: Ang II, AngII, Hypertension, Salt Homeostasis, Pre-eclampsia...
Homo sapiens retinoid X receptor, alpha...
Human Serpin B5/Maspin Affinity Purified Polyclonal Ab...
... 19 x 29 cm, 1. One ... staining of Coomassie Blue or silver-stain gels ... blots for high sensitivity ECL detection and ... volume, and processing time.Proven design for consistent, ...
Biology Products: